All
Chemical peels still have role
May 1st 2005New Orleans — Although laser cosmetic procedures have captured popular attention, chemical peels continue to be appropriate for many patients, according to Suzan Obagi, M.D., at the annual cosmetic surgery symposium of the American College of Oral and Maxillofacial Surgeons.
Rhythmic changes influence female skin susceptibility
May 1st 2005Orlando, Fla. — Fluctuations in estrogen and progesterone during the menstrual cycle can cause changes to the reproductive system, yet little attention has been paid to how these variations may impact the body's largest organ, the skin.
Mosquito abatement, effective repellents key to eradicating West Nile Virus
May 1st 2005Newport Beach, Calif. — The West Nile Virus outbreak in New York City in 1999 provided important lessons in prevention, abatement and repellent use. The New York area health departments quickly began public health programs, according to Tissa R. Hata, M.D., speaking at the Pacific Dermatology Meeting, here.
New class of UV absorbers emerging
May 1st 2005New Orleans — An emerging new class of organic, insoluble UV absorbers shows promise in providing improved broad-spectrum UVB and UVA sunscreen protection and meets the increasing demand of consumers and dermatologists, according to chemist Uli Osterwalder. He reports that the first representative of this UV absorber — bisoctrizole — has been used in sunscreens in European countries for five years and is now being submitted to the U.S. Food and Drug Administration (FDA) for approval.
Skin regeneration through growth hormone factors
May 1st 2005Tokyo — Growth factors offer seemingly endless potential to skin wound repair and regeneration, yet there are several questions surrounding those that are exogenously applied to acute or chronic skin wounds, according to Xiaobing Fu, M.D., professor, Wound Healing and Cell Biology Laboratory, Burns Institute, The General Hospital of PLA, Beijing, China.
Tacrolimus, UVB therapy synergistic duo
May 1st 2005Nice, France — Results of a comparative, prospective, randomized study undertaken by French dermatologists indicate that topical tacrolimus ointment 0.1 percent (Protopic, Fujisawa) plus phototherapy with a 308-nm excimer laser can be a highly effective combination for the treatment of recalcitrant, localized vitiligo.
SD doxycycline: New rosacea therapeutic option
May 1st 2005New Orleans — Results of a multicenter phase 3, randomized, double-blind, placebo-controlled trial demonstrate the safety and efficacy of a subantimicrobial-dose (SD) of doxycycline for the treatment of rosacea, said Diane M. Thiboutot, M.D., at the 63rd Annual Meeting of the American Academy of Dermatology here.
West Nile virus skin symptoms documented
May 1st 2005New Orleans — Scientific literature rarely portrays cutaneous manifestations of West Nile virus (WNV) because these manifestations are, by nature, transient. However, a recent case report contains what is only the second publication of these symptoms.
UV-filtering contact lenses not protective
May 1st 2005The recent influx of contact lenses containing ultraviolet (UV) filters has prompted some patients to inquire about using these as protection after PUVA therapy, rather than coated prescription glasses, sunglasses or UV opaque protective goggles. But as Suliman Otman, M.D., M.S., a clinical research fellow at the Welsh Institute of Dermatology at Cardiff University, England, discovered, UV-blocking contact lenses are not suitable eye protection for people receiving Psoralen in combination with UVA light.
Can CME, experience offset doctors' age-related decline?
May 1st 2005National report — Does practice make perfect? A recent Harvard Medical School review suggests that as physicians age, the quality of care they provide decreases — the plethora of continuing medical education (CME) options available and the presumed benefits of wisdom notwithstanding.
Emergencies: Be prepared for inevitable
May 1st 2005New Orleans — Whether it is serious intraoperative bleeding, the presence of a life-threatening disease or a lethal drug reaction, the dermatologist's office should be prepared for the emergent crisis that can happen at any time and anywhere, Glenn D. Goldman, M.D., says.
'I am importing cheaper medications from Canada. How can I be in trouble?'
May 1st 2005There is still a natural desire to get the same medications from a cheaper source. Dr. Sue turned to Canada. Other physicians have turned to Europe and South America. But whatever the source, Dr. Sue's actions are illegal.
Overuse of black box warnings is scare tactic
May 1st 2005As the Vioxx/Celebrex scandal lays waste to the American healthcare landscape as we know it, the U.S. Food and Drug Administration (FDA) finds itself under relentless pressure to get things right. Congress is demanding more stringent safety standards and even threatening to create a new federal agency to take safety approvals and monitoring out of the FDA's hands.